Efficacy of Transversus Thoracis Muscle Plane Block in Patients Undergoing Cardiac Surgery - Trial NCT06239025
Access comprehensive clinical trial information for NCT06239025 through Pure Global AI's free database. This Phase 4 trial is sponsored by Hôpital du Valais and is currently Not yet recruiting. The study focuses on Postoperative Pain. Target enrollment is 100 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Hôpital du Valais
Timeline & Enrollment
Phase 4
Apr 01, 2024
Apr 30, 2026
Primary Outcome
opioid consumption
Summary
The goal of this randomized double blind study is to evaluate the analgesic efficacy of
 Transversus Thoracis Muscle Plane Block in patients undergoing cardiac surgery with median
 sternotomy.
 
 one group of participants will receive multimodal analgesia plus ultrasound-guided
 Transversus Thoracis Muscle Plane Block with ropivacaine 0.5 % after induction of general
 anesthesia, the other group will receive multimodal analgesia without a bloc.
 
 The investigators want to know if participants who receive the Transversus Thoracis Muscle
 Plane Block with ropivacaine have less pain than participants who do not receive a block.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06239025
Non-Device Trial